MedPath

IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

IMFINZI 50 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

1181322002

Prescription Type

Uso Hospitalario

Authorization Date

Oct 31, 2018

Dosage Form

CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1181322002
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

DURVALUMABActive
Quantity: 120 mg
Name: DURVALUMAB

ATC CLASSIFICATION (3)

L01F
L01FF
L01FF03

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.